Back to WA Weiss Asset Management LP
BIBIOMARIN PHARMACEUTICAL
Showing 0 of 3 quarters
Position history for WAWeiss Asset Management LP's holdings in BIOMARIN PHARMACEUTICAL
No. Weiss Asset Management exited its BIOMARIN PHARMACEUTICAL position in Q4 2020. Its Q3 2020 13F listed 65,841,000 shares worth $64.4M. Weiss Asset Management first reported BIOMARIN PHARMACEUTICAL in Q2 2020 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.